Serotonin Effect in Functional Dyspepsia
NCT00115362 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2007-09-24
Summary
The purpose of this study is to investigate whether Efexor (venlafaxine) is effective in the treatment of functional dyspepsia.
Conditions
- Dyspepsia
Interventions
- DRUG
-
venlafaxine
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Jan Jansen, Professor MD · Radboud University Nijmegen Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Completion
- 2007-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
A Study Of New Medicine (GSK 372475) For The Treatment Of Depression
NCT00448058 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Dyspepsia Treatment Trial
NCT00248651 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
MetAbolism vaRiability of VEnLafaxine
NCT02590185 ·Status: UNKNOWN ·Phase: NA
-
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study
NCT01282814 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Imaging Techniques That Predict Antidepressant Responsiveness
NCT00909155 ·Status: COMPLETED ·Phase: NA
-
Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl
NCT00788944 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Venlafaxine ER in Recurrent Depression
NCT00046020 ·Status: COMPLETED ·Phase: PHASE4
-
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions
NCT01260896 ·Status: COMPLETED ·Phase: PHASE1
-
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
NCT01485887 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
NCT00247429 ·Status: COMPLETED
-
Treatments for Depression: Drug Versus Psychotherapy
NCT00043550 ·Status: COMPLETED ·Phase: PHASE3
-
Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
NCT01441440 ·Status: COMPLETED ·Phase: PHASE3
-
Sexual Functioning Study With Antidepressants
NCT00316160 ·Status: COMPLETED ·Phase: PHASE4
-
Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine
NCT04207385 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom Disorder
NCT06803485 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Desvenlafaxine in Treating Major Depressive Disorder.
NCT04364997 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
NCT00177528 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
NCT00474708 ·Status: COMPLETED ·Phase: PHASE4
-
Physiologic Monitoring of Antidepressant Treatment Response
NCT00759317 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation
NCT03190772 ·Status: COMPLETED ·Phase: NA
-
Venlafaxine 25 mg Tablets Under Fasting Conditions
NCT00834964 ·Status: COMPLETED ·Phase: PHASE1
-
Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
NCT00073411 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females
NCT00818155 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects
NCT00329186 ·Status: COMPLETED ·Phase: PHASE3
-
A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions
NCT00871364 ·Status: COMPLETED ·Phase: PHASE1